Open Access
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Publication type: Journal Article
Publication date: 2011-03-15
PubMed ID:
24212665
Cancer Research
Oncology
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
30
35
|
|
|
Journal of Inorganic Biochemistry
31 publications, 2.19%
|
|
|
International Journal of Molecular Sciences
30 publications, 2.12%
|
|
|
Dalton Transactions
28 publications, 1.98%
|
|
|
Molecules
25 publications, 1.76%
|
|
|
Inorganic Chemistry
25 publications, 1.76%
|
|
|
Inorganica Chimica Acta
24 publications, 1.69%
|
|
|
Scientific Reports
23 publications, 1.62%
|
|
|
Applied Organometallic Chemistry
19 publications, 1.34%
|
|
|
RSC Advances
19 publications, 1.34%
|
|
|
Biomedicine and Pharmacotherapy
18 publications, 1.27%
|
|
|
Oncotarget
17 publications, 1.2%
|
|
|
New Journal of Chemistry
17 publications, 1.2%
|
|
|
Cancers
16 publications, 1.13%
|
|
|
Journal of Molecular Structure
16 publications, 1.13%
|
|
|
Pharmaceutics
13 publications, 0.92%
|
|
|
Journal of Biological Inorganic Chemistry
12 publications, 0.85%
|
|
|
International Journal of Biological Macromolecules
11 publications, 0.78%
|
|
|
Journal of Coordination Chemistry
11 publications, 0.78%
|
|
|
Polyhedron
10 publications, 0.71%
|
|
|
Coordination Chemistry Reviews
10 publications, 0.71%
|
|
|
Life Sciences
10 publications, 0.71%
|
|
|
Journal of Medicinal Chemistry
10 publications, 0.71%
|
|
|
PLoS ONE
9 publications, 0.64%
|
|
|
Bioorganic Chemistry
9 publications, 0.64%
|
|
|
Inorganic Chemistry Communication
9 publications, 0.64%
|
|
|
Pharmaceuticals
8 publications, 0.56%
|
|
|
Frontiers in Oncology
8 publications, 0.56%
|
|
|
Journal of Controlled Release
8 publications, 0.56%
|
|
|
Heliyon
8 publications, 0.56%
|
|
|
5
10
15
20
25
30
35
|
Publishers
|
50
100
150
200
250
300
350
400
|
|
|
Elsevier
393 publications, 27.73%
|
|
|
Springer Nature
201 publications, 14.18%
|
|
|
MDPI
148 publications, 10.44%
|
|
|
Wiley
112 publications, 7.9%
|
|
|
Royal Society of Chemistry (RSC)
105 publications, 7.41%
|
|
|
American Chemical Society (ACS)
101 publications, 7.13%
|
|
|
Taylor & Francis
62 publications, 4.38%
|
|
|
Frontiers Media S.A.
29 publications, 2.05%
|
|
|
Spandidos Publications
27 publications, 1.91%
|
|
|
Impact Journals
23 publications, 1.62%
|
|
|
Hindawi Limited
20 publications, 1.41%
|
|
|
Bentham Science Publishers Ltd.
20 publications, 1.41%
|
|
|
Oxford University Press
15 publications, 1.06%
|
|
|
Mary Ann Liebert
10 publications, 0.71%
|
|
|
Public Library of Science (PLoS)
10 publications, 0.71%
|
|
|
Cold Spring Harbor Laboratory
10 publications, 0.71%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
8 publications, 0.56%
|
|
|
King Saud University
7 publications, 0.49%
|
|
|
SAGE
7 publications, 0.49%
|
|
|
Walter de Gruyter
5 publications, 0.35%
|
|
|
Brieflands
5 publications, 0.35%
|
|
|
Pleiades Publishing
4 publications, 0.28%
|
|
|
Science Alert
4 publications, 0.28%
|
|
|
Portland Press
3 publications, 0.21%
|
|
|
IOP Publishing
3 publications, 0.21%
|
|
|
Asian Pacific Organization for Cancer Prevention
3 publications, 0.21%
|
|
|
Japanese Society of Toxicology
3 publications, 0.21%
|
|
|
AME Publishing Company
3 publications, 0.21%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
2 publications, 0.14%
|
|
|
50
100
150
200
250
300
350
400
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.4k
Total citations:
1417
Citations from 2025:
122
(8.61%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Florea A., Büsselberg D. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects // Cancers. 2011. Vol. 3. No. 1. pp. 1351-1371.
GOST all authors (up to 50)
Copy
Florea A., Büsselberg D. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects // Cancers. 2011. Vol. 3. No. 1. pp. 1351-1371.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/cancers3011351
UR - https://doi.org/10.3390/cancers3011351
TI - Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
T2 - Cancers
AU - Florea, Ana-Maria
AU - Büsselberg, Dietrich
PY - 2011
DA - 2011/03/15
PB - MDPI
SP - 1351-1371
IS - 1
VL - 3
PMID - 24212665
SN - 2072-6694
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2011_Florea,
author = {Ana-Maria Florea and Dietrich Büsselberg},
title = {Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects},
journal = {Cancers},
year = {2011},
volume = {3},
publisher = {MDPI},
month = {mar},
url = {https://doi.org/10.3390/cancers3011351},
number = {1},
pages = {1351--1371},
doi = {10.3390/cancers3011351}
}
Cite this
MLA
Copy
Florea, Ana-Maria, and Dietrich Büsselberg. “Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects.” Cancers, vol. 3, no. 1, Mar. 2011, pp. 1351-1371. https://doi.org/10.3390/cancers3011351.